Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

307 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recommendation for treatment of hepatitis C virus infection.
Kaymakoğlu S, Köksal İ, Tabak F, Akarca US, Akbulut A, Akyüz F, Bodur H, Çağatay A, Dinçer D, Esen Ş, Güner R, Gürel S, Köse Ş, Şentürk Ö, Şimşek H, Yamazhan T, Yılmaz Y, Idilman R, Guidelines Study Group VH. Kaymakoğlu S, et al. Among authors: bodur h. Turk J Gastroenterol. 2017 Dec;28(Suppl 2):94-100. doi: 10.5152/tjg.2017.22. Turk J Gastroenterol. 2017. PMID: 29303106 Free article. No abstract available.
Predictors of response to pegylated interferon treatment in HBeAg-negative patients with chronic hepatitis B.
Guclu E, Tuna N, Karabay O, Akhan S, Bodur H, Ceylan B, Demirdal T, Demirdag K, Demirturk N, Ekerbicer H, Erol S, Esen S, Evirgen O, Geyik MF, Gunduz A, Karahocagil MK, Kokoglu OF, Ozdemir D, Ozgunes N, Sargın F, Tosun S, Tutuncu E. Guclu E, et al. Among authors: bodur h. J Infect Dev Ctries. 2014 Dec 15;8(12):1601-8. doi: 10.3855/jidc.4953. J Infect Dev Ctries. 2014. PMID: 25500658 Free article.
A micro-elimination approach to addressing hepatitis C in Turkey.
Idilman R, Razavi H, Robbins-Scott S, Akarca US, Örmeci N, Kaymakoglu S, Aygen B, Tozun N, Güner R, Bodur H, Lazarus JV. Idilman R, et al. Among authors: bodur h. BMC Health Serv Res. 2020 Mar 24;20(1):249. doi: 10.1186/s12913-020-5019-8. BMC Health Serv Res. 2020. PMID: 32209103 Free PMC article.
Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls.
Mert A, Vahaboğlu H, Arslan F, Batirel A, Saraçoğlu KT, Bastug A, Çağatay A, Irmak İ, Dizman GT, Ertenli İ, Altunal LN, Sengel BE, Bayram M, Omma A, Amikishiyev S, Aypak A, Bes C, Bolukçu S, Içten S, Topeli A, Bektaş M, Arslan BY, Öztürk S, Çomoğlu Ş, Aydin S, Küçükşahin O, Içaçan OC, Ince B, Aghamuradov S, Mutlu MY, Şimşek F, Emre S, Ustun C, Ergen P, Aydin Ö, Koç MM, Sevindik ÖG, Odabaşı Z, Korten V, Bodur H, Güner R, Ünal S, Kocak M, Gül A. Mert A, et al. Among authors: bodur h. Rheumatol Int. 2022 Mar;42(3):457-467. doi: 10.1007/s00296-021-04965-6. Epub 2021 Sep 13. Rheumatol Int. 2022. PMID: 34515808 Free PMC article.
In a Real-Life Setting, Direct-Acting Antivirals to People Who Inject Drugs with Chronic Hepatitis C in Turkey.
Sarıgül Yıldırım F, Üser Ü, Sarı ND, Kurtaran B, Önlen Y, Şenateş E, Gündüz A, Zerdali E, Karsen H, Batırel A, Karaali R, Güner R, Yamazhan T, Köse Ş, Erben N, İnce N, Köksal İ, Çuvalcı Öztoprak N, Yörük G, Kömür S, Bal T, Kaya S, Bozkurt İ, Günal Ö, Yıldız İE, İnan D, Barut Ş, Namıduru M, Tosun S, Türker K, Şener A, Hızel K, Baykam N, Duygu F, Bodur H, Can G, Gül HC, Sağmak Tartar A, Çelebi G, Sünnetçioğlu M, Karabay O, Kumbasar Karaosmanoğlu H, Sırmatel F, Tabak F. Sarıgül Yıldırım F, et al. Among authors: bodur h. Turk J Gastroenterol. 2022 Nov;33(11):971-978. doi: 10.5152/tjg.2022.21834. Turk J Gastroenterol. 2022. PMID: 36415900 Free PMC article.
Multi-center prospective evaluation of discharge criteria for hospitalized patients with Crimean-Congo Hemorrhagic Fever.
Leblebicioglu H, Sunbul M, Barut S, Buyuktuna SA, Ozkurt Z, Yapar D, Yilmaz G, Guner R, But A, Cicek Senturk G, Murat N, Ozaras R; Crimean Congo Hemorrhagic Fever Research Network of Turkey. Leblebicioglu H, et al. Antiviral Res. 2016 Sep;133:9-13. doi: 10.1016/j.antiviral.2016.07.010. Epub 2016 Jul 15. Antiviral Res. 2016. PMID: 27424492
Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir.
Guner R, Hasanoglu I, Kayaaslan B, Aypak A, Akinci E, Bodur H, Eser F, Kaya Kalem A, Kucuksahin O, Ates I, Bastug A, Tezer Tekce Y, Bilgic Z, Gursoy FM, Akca HN, Izdes S, Erdem D, Asfuroglu E, Hezer H, Kilic H, Cıvak M, Aydogan S, Buzgan T. Guner R, et al. Among authors: bodur h. J Infect Public Health. 2021 Mar;14(3):365-370. doi: 10.1016/j.jiph.2020.12.017. Epub 2020 Dec 29. J Infect Public Health. 2021. PMID: 33647553 Free PMC article.
307 results